Biotech Showcase will give you the opportunity to connect with your peers in-person in San Francisco this January.
February 2024 – “A promising biotech startup in cancer immunotherapy” Labiotech Cancer vaccines: 10 biotech companies that have changed the game
VacV Biotherapeutics (“VacV” or “the Company”), a cancer immunotherapy company developing innovative viral-based therapies, emerged from stealth mode today to advance its promising pipeline of pre-clinical assets with best-in-class potential, towards the clinic.
